Skip to main content

Advertisement

SpringerLink
Log in

Biomarkers Associated with Ischemic Stroke in Diabetes Mellitus Patients

  • Published:
Cardiovascular Toxicology Aims and scope Submit manuscript

Abstract

Diabetes is an established risk factor for ischemic stroke, but the associated molecular mechanisms remain to be fully elucidated. This study investigated the role of plasma and platelet microRNAs and their targeting proteins in the activation of platelets and their association with the occurrence of ischemic stroke in patients with type 2 diabetes mellitus (T2DM). Results showed that the expressions of platelet and plasma miR-144 and miR-223 were significantly altered in T2DM patients with or without ischemic stroke compared to that in healthy controls, but these changes were more significant in T2DM patients with ischemic stroke. The expressions of P2Y12 and IRS-1 as well as phosphorylation levels of IRS-1, PI3K, and Akt in platelets were significantly altered in T2DM patients with or without ischemic stroke. The expression of platelet miR-144 and miR-223 significantly correlated with their plasma levels, P2Y12 and IRS-1 expression, blood glucose concentration, and platelet activation rate. High glucose concentration significantly elevated P-selectin, miR-144 and P2Y12 expression and significantly reduced miR-223 and IRS-1 expression in UT-7 cells. Overexpression of miR-223 and blocking of miR-144 expression significantly normalized the effects of high glucose concentration in UT-7 cells. In conclusion, hyperglycemia may activate platelets through miR-144 and miR-223 to downregulate IRS-1 and upregulate P2Y12 expression in the platelets of T2DM patients through an IRS-1–PI3K–Akt signaling. Low platelet and plasma miR-223 expression in addition to high platelet and plasma miR-144 expression are risk factors for ischemic stroke in T2DM patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Gerrits, A. J., Koekman, C. A., van Haeften, T. W., & Akkerman, J. W. (2010). Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin. Diabetes, 59, 1487–1495.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Nakagami, H., Kaneda, Y., Ogihara, T., & Morishita, R. (2005). Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis. Current Diabetes Review, 1, 59–63.

    Article  CAS  Google Scholar 

  3. Burchfiel, C. M., Curb, J. D., Rodriguez, B. L., Abbott, R. D., Chiu, D., & Yano, K. (1994). Glucose intolerance and 22-year stroke incidence. The Honolulu Heart Program. Stroke, 25, 951–957.

    Article  CAS  PubMed  Google Scholar 

  4. Ferreiro, J. L., Gomez-Hospital, J. A., & Angiolillo, D. J. (2010). Platelet abnormalities in diabetes mellitus. Diabetes and Vascular Disease Research, 7, 251–259.

    Article  PubMed  Google Scholar 

  5. Todd Cade, W. (2008). Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Physical Therapy, 88, 1322–1335.

    Article  PubMed  Google Scholar 

  6. Kirshner, H. S. (2009). Differentiating ischemic stroke subtypes: Risk factors and secondary prevention. Journal of the Neurological Sciences, 279, 1–8.

    Article  PubMed  Google Scholar 

  7. Jackson, S. P., Nesbitt, W. S., & Kulkarni, S. (2003). Signaling events underlying thrombus formation. Journal of Thrombosis and Haemostasis, 1, 1602–1612.

    Article  CAS  PubMed  Google Scholar 

  8. Dorsam, R. T., & Kunapuli, S. P. (2004). Central role of the P2Y12 receptor in platelet activation. Journal of Clinical Investigation, 113, 340–345.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Jin, J., Quinton, T. M., Zhang, J., Rittenhouse, S. E., & Kunapuli, S. P. (2002). Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors. Blood, 99, 193–198.

    Article  CAS  PubMed  Google Scholar 

  10. Brozinick, J. T, Jr, Roberts, B. R., & Dohm, G. L. (2003). Defective signaling through Akt-2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle: Potential role in insulin resistance. Diabetes, 52, 935–941.

    Article  CAS  PubMed  Google Scholar 

  11. Mardilovich, K., Pankratz, S. L., & Shaw, L. M. (2009). Expression and function of the insulin receptor substrate proteins in cancer. Cell Communication and Signaling, 7, 14.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Bruchova, H., Merkerova, M., & Prchal, J. T. (2008). Aberrant expression of microRNA in polycythemia vera. Haematologica, 93, 1009–1016.

    Article  CAS  PubMed  Google Scholar 

  13. Bartel, D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell, 136, 215–233.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Evans, D. J., Jackman, L. E., Chamberlain, J., Crosdale, D. J., Judge, H. M., Jetha, K., et al. (1992). Platelet P2Y(12) receptor influences the vessel wall response to arterial injury and thrombosis. Circulation, 119, 116–122.

    Article  Google Scholar 

  15. Hartwig, J. H. (1992). Mechanisms of actin rearrangements mediating platelet activation. Journal of Cell Biology, 118, 1421–1442.

    Article  CAS  PubMed  Google Scholar 

  16. Kondratov, R. V., Chernov, M. V., Kondratova, A. A., Gorbacheva, V. Y., Gudkov, A. V., & Antoch, M. P. (2003). BMAL1-dependent circadian oscillation of nuclear CLOCK: Posttranslational events induced by dimerization of transcriptional activators of the mammalian clock system. Genes & Development, 17, 1921–1932.

    Article  CAS  Google Scholar 

  17. Li, J., Rohailla, S., Gelber, N., Rutka, J., Sabah, N., Gladstone, R. A., et al. (2014). MicroRNA-144 is a circulating effector of remote ischemic preconditioning. Basic Research in Cardiology, 109, 423.

    Article  PubMed  Google Scholar 

  18. Duan, X., Zhan, Q., Song, B., Zeng, S., Zhou, J., Long, Y., et al. (2014). Detection of platelet microRNA expression in patients with diabetes mellitus with or without ischemic stroke. Journal of Diabetes and Its Complications, 28, 705–710.

    Article  PubMed  Google Scholar 

  19. Landry, P., Plante, I., Ouellet, D. L., Perron, M. P., Rousseau, G., & Provost, P. (2009). Existence of a microRNA pathway in anucleate platelets. Nature Structural & Molecular Biology, 16, 961–966.

    Article  CAS  Google Scholar 

  20. Karolina, D. S., Armugam, A., Tavintharan, S., Wong, M. T., Lim, S. C., Sum, C. F., & Jeyaseelan, K. (2011). MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One, 6, e22839.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Michelson, A. D., Barnard, M. R., Krueger, L. A., Frelinger, A. L, 3rd, & Furman, M. I. (2000). Evaluation of platelet function by flow cytometry. Methods, 21, 259–270.

    Article  CAS  PubMed  Google Scholar 

  22. Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Science USA, 105, 10513–10518.

    Article  CAS  Google Scholar 

  23. Bai, M., Zhu, X., Zhang, Y., Zhang, S., Zhang, L., Xue, L., et al. (2012). Abnormal hippocampal BDNF and miR-16 expression is associated with depression-like behaviors induced by stress during early life. PLoS One, 7, e46921.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Zhang, X., Li, Y., Huang, Q., Wang, H., Yan, B., Dewhirst, M. W., & Li, C. Y. (2003). Increased resistance of tumor cells to hyperthermia mediated by integrin-linked kinase. Clinical Cancer Research, 9, 1155–1160.

    CAS  PubMed  Google Scholar 

  25. Ferreira, I. A., Mocking, A. I., Feijge, M. A., Gorter, G., van Haeften, T. W., Heemskerk, J. W., & Akkerman, J. W. (2006). Platelet inhibition by insulin is absent in type 2 diabetes mellitus. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 417–422.

    Article  CAS  PubMed  Google Scholar 

  26. Angiolillo, D. J., Bernardo, E., Zanoni, M., Vivas, D., Capranzano, P., Malerba, G., et al. (2011). Impact of insulin receptor substrate-1 genotypes on platelet reactivity and cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease. Journal of the American College of Cardiology, 58, 30–39.

    Article  CAS  PubMed  Google Scholar 

  27. Dangwal, S., & Thum, T. (2012). MicroRNAs in platelet biogenesis and function. Thrombosis and Haemostasis, 108, 599–604.

    Article  CAS  PubMed  Google Scholar 

  28. Zimmerman, G. A., & Weyrich, A. S. (2008). Signal-dependent protein synthesis by activated platelets: New pathways to altered phenotype and function. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, s17–s24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Zampetaki, A., Kiechl, S., Drozdov, I., Willeit, P., Mayr, U., Prokopi, M., et al. (2010). Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circulation Research, 107, 810–817.

    Article  CAS  PubMed  Google Scholar 

  30. Ferreira, I. A., Mocking, A. I., Feijge, M. A., Gorter, G., van Haeften, T. W., Heemskerk, J. W., & Akkerman, J. W. (2006). Platelet inhibition by insulin is absent in type 2 diabetes mellitus. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 417–422.

    Article  CAS  PubMed  Google Scholar 

  31. Shantsila, E., Kamphuisen, P. W., & Lip, G. Y. (2010). Circulating microparticles in cardiovascular disease: Implications for atherogenesis and atherothrombosis. Journal of Thrombosis and Haemostasis, 8, 2358–2368.

    Article  CAS  PubMed  Google Scholar 

  32. Diehl, P., Fricke, A., Sander, L., Stamm, J., Bassler, N., Htun, N., et al. (2012). Microparticles: Major transport vehicles for distinct microRNAs in circulation. Cardiovascular Research, 93, 633–644.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study was supported by Changsha Science and Technology Plan (K0902033-31), Hunan Science and Technology Plan (2009FJ3209), National Hi-tech Project of China (2007AA021809), Key Project of International Cooperation, Ministry of Science and Technology of China (2010DFB30300), and National Natural Science Foundation of China (No: 81272193).

Conflict of interest

The authors declared no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Endocrinology, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha, 410008, People’s Republic of China

    Shuisheng Yang & Minxiang Lei

  2. Hepatobiliary Enteric Surgery Research Center, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, People’s Republic of China

    Jingfeng Zhao & Yuxiang Chen

Authors
  1. Shuisheng Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jingfeng Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuxiang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Minxiang Lei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yuxiang Chen or Minxiang Lei.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, S., Zhao, J., Chen, Y. et al. Biomarkers Associated with Ischemic Stroke in Diabetes Mellitus Patients. Cardiovasc Toxicol 16, 213–222 (2016). https://doi.org/10.1007/s12012-015-9329-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12012-015-9329-8

Keywords

Search

Navigation